首页> 美国卫生研究院文献>OncoTargets and therapy >Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

【2h】

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

机译：阿帕替尼联合艾克替尼治疗艾克替尼治疗失败后晚期非小细胞肺癌的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTreatment failure frequently occurs in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) who respond to EGFR tyrosine kinase inhibitors initially. This retrospective study tried to investigate the efficacy and safety of apatinib plus icotinib in patients with advanced NSCLC after icotinib treatment failure.

机译：背景治疗失败通常发生在表皮生长因子受体（EGFR）突变的非小细胞肺癌（NSCLC）患者中，这些患者最初对EGFR酪氨酸激酶抑制剂有反应。这项回顾性研究试图探讨阿帕替尼加艾克替尼对艾克替尼治疗失败后晚期NSCLC患者的疗效和安全性。

著录项

期刊名称 OncoTargets and therapy
作者
Jianping Xu; Xiaoyan Liu; Sheng Yang; Xiangru Zhang; Yuankai Shi;
展开▼
作者单位

展开▼
年(卷),期 2017(10),-1
年度 2017
页码 4989–4995
总页数 7
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
epidermal growth factor receptor mutation non-small cell lung cancer apatinib icotinib efficacy;

机译：表皮生长因子受体突变;非小细胞肺癌;阿帕替尼;艾克替尼;疗效;
入库时间 2022-08-17 12:28:22

相似文献

外文文献
中文文献
专利

1. Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study [J] . Jianping Xu, Xiaoyan Liu, Sheng Yang, OncoTargets and therapy . 2017,第6期

机译：阿帕替尼联合艾克替尼治疗艾克替尼治疗失败后晚期非小细胞肺癌的回顾性研究
2. Icotinib alone or with bevacizumab as first-line therapy in Chinese patients with advanced nonsquamous non-small cell lung cancer and activating EGFR mutations: A retrospective study [J] . Zhansheng Jiang, Jing Zhang, Haiyan Sun, Thoracic cancer. . 2021,第17期

机译：单独的icotinib或贝伐单抗作为中国晚期非小细胞肺癌患者的一线治疗和激活EGFR突变：回顾性研究
3. A single-arm, multicenter, safety-monitoring, phase IV study of icotinib in treating advanced non-small cell lung cancer (NSCLC) [J] . HuX., HanB., GuA., Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2014,第2期

机译：艾考替尼治疗晚期非小细胞肺癌（NSCLC）的单臂，多中心，安全监测，IV期研究
4. SAHA Treatment Reveals the Link between Histone Lysine Acetylation and Proteome in Non-small Cell Lung Cancer A549 Cells [C] . Quan Wu, Weiqing Xu, Lejie Cao, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：Saha治疗揭示了非小细胞肺癌A549细胞中组蛋白赖氨酸乙酰化和蛋白质组之间的联系
5. Predictive Biomarkers of the Efficacy of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Treating Advanced Non-small Cell Lung Cancer: A Systematic Review of Randomized Controlled Trials [D] . Yang, Zuyao. 2014

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌疗效的预测生物标志物：随机对照试验的系统评价。
6. The Efficacy and Safety of Icotinib in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Chemotherapy: A Single-Arm Multi-Center Prospective Study [O] . Xingsheng Hu, Li Zhang, Yuankai Shi, -1

机译：Icotinib对先前接受化疗的晚期非小细胞肺癌患者的疗效和安全性：单臂多中心前瞻性研究
7. Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study [O] . Jianping Xu, Xiaoyan Liu, Sheng Yang, 2017

机译：Apatinib加icotinib在icotinib治疗失败后治疗晚期非小细胞肺癌：回顾性研究

Apatinib plus icotinib in treating advanced non-small cell lung cancer after icotinib treatment failure: a retrospective study

摘要

著录项

相似文献

相关主题

期刊订阅